These experiments revealed that TGFbeta-1 upregulates the expression of FAP in human permanent and non-stem glioma cell cultures, brain vascular pericytes, and glioblastoma-derived endothelial cells and FAP+ mesenchymal cells. This evidence concerns the gene FAP and central nervous system cancer.